Methylation profiling

Dataset Information

0

Tamoxifen induction of Cre recombinase does not cause long lasting or sexually divergent responses in the CNS epigenome or transcriptome: implications for the design of aging studies.

ABSTRACT: The systemic delivery of tamoxifen (Tam) to activate inducible CreERT2-loxP transgenic mouse systems is now widely used in neuroscience studies. This critical technological advancement allows temporal control of DNA-cre recombination, avoidance of embryonically lethal phenotypes, and minimization of residual cell labeling encountered in constitutively active drivers. Despite its advantages, the use of Tam has the potential to cause long-lasting, uncharacterized side effects on the transcriptome and epigenome in the CNS, given its mixed estrogen receptor (ER) agonist/antagonist actions. With the welcome focus on including both sexes in biomedical studies and efforts to understand sex differences, Tam administration could also cause sexually divergent responses that would confound studies. To examine these issues, epigenetic and transcriptomic profiles were compared in C57BL/6J female and male hippocampus, cortex, and retina 1 month after a five- day Tam treatment typical for cre induction, or vehicle control (sunflower seed oil). Cytosine methylation and hydroxymethylation levels, in both CG and non-CG contexts, were unchanged as determined by oxidative bisulfite sequencing. Long-lasting Tam transcriptomic effects were also not evident/minimal. Furthermore, there is no evidence of sexually divergent responses with Tam administration and Tam did not alter sex differences evident in controls. Combined with recently reported data that Tam alone does not cause long-lasting changes in behavior and neurogenesis, our findings provide confidence that Tam can be used as a cre-recombinase inducer without introducing significant confounds in transcriptomic and epigenomic neuroscience studies, particularly those focused on genomic and transcriptomic aspects of the aging brain.

ORGANISM(S): Mus musculus

PROVIDER: GSE135208 | GEO | 2019/08/01

REPOSITORIES: GEO

Json Xml

Dataset's files

Source:
Action DRS
Other
Items per page:
1 - 1 of 1

Similar Datasets

Transcriptomics Tamoxifen induction of Cre recombinase does not cause long lasting or sexually divergent responses in the CNS epigenome or transcriptome: implications for the design of aging studies (RNA-Seq).
2019-08-13 | GSE135752 | GEO
Transcriptomics Reproducible specificity and efficiency of tamoxifen-mediated cre induction across ages
2023-12-14 | GSE241574 | GEO
Genomics Tamoxifen induction of Cre recombinase does not cause long lasting or sexually divergent responses in the CNS epigenome or transcriptome: implications for the design of aging studies.
| PRJNA557725 | ENA
Genomics Tamoxifen induction of Cre recombinase does not cause long lasting or sexually divergent responses in the CNS epigenome or transcriptome: implications for the design of aging studies (RNA-Seq).
| PRJNA559894 | ENA
Transcriptomics Inducible cell-specific mouse models for paired epigenetic and transcriptomic studies of microglia and astroglia: RNA-Seq Data
2020-01-01 | GSE140895 | GEO
Transcriptomics Inducible cell-specific mouse models for paired epigenetic and transcriptomic studies of microglia and astroglia: Cx3cr1+;NT+ Hippocampus RNA-Seq Data
2020-10-07 | GSE159106 | GEO
Transcriptomics Inducible cell-specific mouse models for paired epigenetic and transcriptomic studies of microglia and astroglia: LPS Experiment RNA-Seq Data
2020-01-01 | GSE140974 | GEO
Methylation profiling Inducible cell-specific mouse models for paired epigenetic and transcriptomic studies of microglia and astroglia: Whole Genome oxidative bisulfite sequencing data
2020-01-01 | GSE140271 | GEO
Transcriptomics DICER controls macrophage polarization and tumor response to immunotherapy
2016-06-13 | E-GEOD-76356 | biostudies-arrayexpress
Genomics Regulation ot TAM gene expression by ABCA1 and ABCG1 (4 Cre- and 4 Cre+)
| PRJNA520922 | ENA